Roche Diagnostics CONFIRM anti-Desmin (DE-R-11) PAb; ROCHGSK-05267005001

Roche Diagnostics Corporation CONFIRM anti-Desmin (DE-R-11) PAb; This antibody is intended for in vitro diagnostic (IVD) use. Ventana Medical Systems, Inc. (Ventana) CONFIRM anti-Desmin (DE-R-11) Primary Antibody is a mouse monoclonal antibody (IgG1, light chain kappa) directed against desmin. This antibody is intended for use to qualitatively identify desmin in myocytic cells by light microscopy in sections of formalin fixed, paraffin embedded tissue on a Ventana automated slide stainer. CONFIRM anti-Desmin (DE-R-11) may be used to aid in the identification of cells of normal and abnormal myocytic lineage as an aid in diagnosis of anaplastic tumors. CONFIRM anti-Desmin (DE-R-11) specifically binds to antigens located in the cytoplasm of myocytic cells. The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests. Prescription only. 50 Tests - ROCHGSK (Additional S&H or Hazmat Fees May Apply)